In the News - Q1 Productions

This Week’s Top Headlines

Allergan Pharmaceuticals and Editas Medicine Confirm CRISPR Deal

Posted 3/16/17

Allergan and Editas Medicine have confirmed a research and development alliance under which Allergan will have exclusive access to and the right to license up to five Edits genome-editing eye disease therapies. The treatment involves CRISPR technology which edits genomes to replace or remove diseased cells. This technology is the latest innovation in eye disease treatment. The deal comes after Allergan’s unveiling of their new program, “See America,” last month which aims to educate about eye diseases. Read the full press release here.

Generic Pharma In Favor of Quicker FDA Approvals

Posted 3/16/17

Biosimilar and generic drug makers have voiced favor over the speedier FDA promised by President Trump. The agency will be aiming to approve more drugs than it did in 2016, when it reached an all-time high of 600 new patents. The quicker approval times may eliminate some approval costs and increase competition between generic and brand-name pharmaceutical makers, which may see reduced prices for patients and payers. Read the full article here.

Research Finds iPhone App Data Comparable to Traditional Studies

Posted 3/16/17

Researchers from the Icahn School of Medicine at Mount Sanai have published their findings that iPhone apps tracking asthma treatment and symptoms presented a safe and cohesive environment for data collection. The study was composed of 7,500 U.S. candidates focused on measuring “real-world” disease patterns such as the correlation between weather conditions and disease flare-ups. Researchers concluded that the data received is comparable to traditional study results. Read the full article here.

Pfizer Releases Antibiotic Aimed at Resistant-Bacteria

Posted 3/16/17

Pfizer has announced the release of an antibiotic used to treat infections caused by resistant bacteria. The antibiotic, Zavicefta, is a combination of avibactam and ceftazidime and will be used for gram-negative infections, in which a rise in resistant bacteria has been traced. Clinical trials have concluded that the new drug is just effective in treating the rare, super-resistant infections. Read the full article here.

MedyMatch and IBM Deliver Real-Time Brain-Bleed Detection Technology

Posted 3/16/17

MedyMatch and IBM have teamed up to deliver a brain-bleed detecting system to hospitals. The system will use artificial intelligence (AI) to determine where bleeding may be present during a CT scan. This technology quickly and efficiently detects the bleeding on-site through a cloud-based system, which may prevent long-term bleeding effects including death. Read the full article here.

At Veranex, we can help you with concept through to commercialization by enabling:
• Accelerated speed to market
• Controlled development costs
• Development risk mitigation
• Market viability assessment

At every stage, we navigate our clients to realize efficiencies in cost and time with our integrated and comprehensive solutions.

Visit Sponsor Website

Since TrainingPros was founded in 1997, we have been dedicated to helping our clients find the right consultant for their projects. 25 years later, we are proud to have helped hundreds of clients complete their projects and thousands of consultants find great assignments. We continue to focus on helping our clients and consultants as well as our community as a certified women-owned, award-winning staffing company that works exclusively with Learning & Development professionals to match consultants to client projects.

Visit Sponsor Website

TELCOR is the proven leader of health care software solutions for revenue cycle management (RCM) software and services designed specifically for laboratories. TELCOR RCM, our SaaS solution, and TELCOR Revenue Cycle Services, our billing service, are designed to streamline workflow, improve collections, and provide real-time analytics. Our software and service solutions are designed for the unique challenges and requirements of laboratory specialties and the clients they serve. With full access to data, labs have complete visibility of their data and can track key performance indicators. No other vendor works as hard ensuring you get paid for the work you do.

Visit Sponsor Website

At Tipping Point Media, we pride ourselves on developing innovative, creative, and technically advanced virtual training and digital marketing solutions for the life sciences industry.

We push the limits of what's possible using Augmented and Virtual Reality to create revolutionary experiences proven to increase audience engagement and retention rates.

Our dedicated team of educators, medical experts, certified programmers, and digital renaissance innovators are committed to creating high-quality custom creations that bring your company's vision to life.

Visit Sponsor Website

VantagePoint Performance trains Salespeople to be more fluent and comfortable across different situations needing different sales approaches, and we train Sales Managers to be better coaches and team leaders, with more focus and less stress.

We’re different from the average sales training company because:

We don’t believe that one approach, one system, or one methodology is absolutely superior. All have something to offer, and the “best approach” or “best system” depends on the sales situation. This is what our applied, academic research tells us.
Our use of data science, specifically Machine Learning, helps us learn about our clients more meaningfully. We provide insights from each client’s data to help them understand what drives the success of their top-performing Salespeople and Sales Managers.
We are constantly feeding what we learn back into our training products, and we invest a bigger slice of our total energy into this innovation than the average sales training company. Our clients can access always-refreshed intellectual property and content through our training subscriptions.

Visit Sponsor Website

Policy Reporter, acquired by TrialCard in 2019, provides innovative healthcare software solutions to track payer policies in near real-time and enhances market access for the therapies patients need most. The company’s patented software-driven solutions include a suite of billing and reimbursement tools for providers and laboratories, market intelligence tools for payers, and a suite of market access solutions for life science companies. Its clients include some of the world’s largest pharmaceutical and healthcare companies.

Visit Sponsor Website